Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Saccharomyces cerevisiae (Beta-1,3/1,6-D-Glucan).
This yeast-derived polysaccharide functions as a biological response modifier by binding to Dectin-1 receptors on macrophages and neutrophils, thereby priming the innate immune system without inducing pro-inflammatory cytokine overproduction.
439261
856.5 g/mol
-8.8
[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [(2R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-[[[(2R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] hydrogen phosphate
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Saccharomyces cerevisiae (Beta-1,3/1,6-D-Glucan) across standard consumer modalities.
The high bulk density and potential hygroscopicity of yeast-derived glucans require careful excipient selection to prevent clumping and ensure consistent flow during encapsulation.
High molecular weight polysaccharides like beta-glucan can interfere with pectin cross-linking, resulting in a grainy texture or compromised structural integrity of the gummy matrix.
The high therapeutic dosage required for effective immunomodulation typically exceeds the limited payload capacity of thin-film matrices, which are generally restricted to doses under 100mg.
Ready to launch a product featuring Saccharomyces cerevisiae (Beta-1,3/1,6-D-Glucan)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Saccharomyces cerevisiae (Beta-1,3/1,6-D-Glucan) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Saccharomyces cerevisiae (Beta-1,3/1,6-D-Glucan) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation